‘Our product giving has expanded rapidly, and we market over a hundred different products on three target markets now.’.. Cellectis bioresearch launches e-store to improve access to meganuclease technology Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis , is pleased to announce the release of its e-store, with approximately one hundred ready-to-use products available for sale online via a new functional and intuitive website. Launched in 2008, Cellectis bioresearch develops and marketplaces a full type of targeted integration kits, that offer a basic, effective method of using Cellectis meganuclease systems.Caution against over-aggressive use of erythropoiesis-stimulating brokers for cancer-related anemia Echoing recent FDA warnings, a study group from Northern Ireland cautions against over-aggressive usage of a group of drugs called ‘erythropoiesis-stimulating agents’ to take care of anemia in a few cancer patients, in the April issue of The Oncologist regarding to a commentary, published by AlphaMed Press. This article by Dr.